Clinical Trial Update: Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Marimastat maintenance or no further therapy in metastatic breast cancer responders/stable after chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Marimastat (marimastat)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED